326 related articles for article (PubMed ID: 28826779)
1. Gene expression profiles in auricle skin as a possible additional endpoint for determination of sensitizers: A multi-endpoint evaluation of the local lymph node assay.
Tsuchiyama H; Maeda A; Nakajima M; Kitsukawa M; Takahashi K; Miyoshi T; Mutsuga M; Asaoka Y; Miyamoto Y; Oshida K
Toxicol Lett; 2017 Oct; 280():133-141. PubMed ID: 28826779
[TBL] [Abstract][Full Text] [Related]
2. Intracellular expression of cytokines and granzyme B in auricular lymph nodes draining skin exposed to irritants and sensitizers.
Ku HO; Jeong SH; Kang HG; Pyo HM; Cho JH; Son SW; Kim HR; Lee KJ; Ryu DY
Toxicology; 2008 Sep; 250(2-3):116-23. PubMed ID: 18652873
[TBL] [Abstract][Full Text] [Related]
3. Application of BALB/c mouse in the local lymph node assay:BrdU-ELISA for the prediction of the skin sensitizing potential of chemicals.
Hou F; Xing C; Li B; Cheng J; Chen W; Zhang M
J Pharmacol Toxicol Methods; 2015; 72():53-8. PubMed ID: 25600862
[TBL] [Abstract][Full Text] [Related]
4. Utilization of the ex vivo LLNA: BrdU-ELISA to distinguish the sensitizers from irritants in respect of 3 end points-lymphocyte proliferation, ear swelling, and cytokine profiles.
Arancioglu S; Ulker OC; Karakaya A
Int J Toxicol; 2015; 34(1):24-30. PubMed ID: 25563296
[TBL] [Abstract][Full Text] [Related]
5. Analysis of differential gene expression in auricular lymph nodes draining skin exposed to sensitizers and irritants.
Ku HO; Jeong SH; Kang HG; Pyo HM; Cho JH; Son SW; Ryu DY
Toxicol Lett; 2008 Feb; 177(1):1-9. PubMed ID: 18242016
[TBL] [Abstract][Full Text] [Related]
6. Contact and respiratory sensitizers can be identified by cytokine profiles following inhalation exposure.
De Jong WH; Arts JH; De Klerk A; Schijf MA; Ezendam J; Kuper CF; Van Loveren H
Toxicology; 2009 Jul; 261(3):103-11. PubMed ID: 19422874
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of an ex vivo murine local lymph node assay: multiple endpoint comparison.
Piccotti JR; Knight SA; Gillhouse K; Lagattuta MS; Bleavins MR
J Appl Toxicol; 2006; 26(4):333-40. PubMed ID: 16705757
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiles and pathways in skin inflammation induced by three different sensitizers and an irritant.
Ku HO; Jeong SH; Kang HG; Pyo HM; Cho JH; Son SW; Yun SM; Ryu DY
Toxicol Lett; 2009 Oct; 190(2):231-7. PubMed ID: 19647056
[TBL] [Abstract][Full Text] [Related]
9. A nonradioisotopic endpoint for measurement of lymph node cell proliferation in a murine allergic contact dermatitis model, using bromodeoxyuridine immunohistochemistry.
Lee JK; Park JH; Park SH; Kim HS; Oh HY
J Pharmacol Toxicol Methods; 2002; 48(1):53-61. PubMed ID: 12750042
[TBL] [Abstract][Full Text] [Related]
10. Intra-laboratory study to determine the reproducibility of LLNA:BrdU-ELISA for the prediction of the skin sensitizing potential of chemicals.
Chen W; Xing C; Hou F
J Pharmacol Toxicol Methods; 2016; 82():26-30. PubMed ID: 27456929
[TBL] [Abstract][Full Text] [Related]
11. Cytokine endpoints for the local lymph node assay: consideration of interferon-gamma and interleukin 12.
Dearman RJ; Hilton J; Basketter DA; Kimber I
J Appl Toxicol; 1999; 19(3):149-55. PubMed ID: 10362264
[TBL] [Abstract][Full Text] [Related]
12. Advantage of using CBA/N strain mice in a non-radioisotopic modification of the local lymph node assay.
Takeyoshi M; Noda S; Yamasaki K; Kimber I
J Appl Toxicol; 2006; 26(1):5-9. PubMed ID: 16217858
[TBL] [Abstract][Full Text] [Related]
13. Further development of LLNA:DAE method as stand-alone skin-sensitization testing method and applied for evaluation of relative skin-sensitizing potency between chemicals.
Yamashita K; Shinoda S; Hagiwara S; Itagaki H
J Toxicol Sci; 2015 Apr; 40(2):137-50. PubMed ID: 25786520
[TBL] [Abstract][Full Text] [Related]
14. [Improvement of local lymph node assay for cosmetics safety evaluation].
Liu Z; Liu J; Wang F; Xu G; Hou J; Wan X; Zhang T
Wei Sheng Yan Jiu; 2009 Sep; 38(5):585-9. PubMed ID: 19877522
[TBL] [Abstract][Full Text] [Related]
15. Differential gene expression responses distinguish contact and respiratory sensitizers and nonsensitizing irritants in the local lymph node assay.
Adenuga D; Woolhiser MR; Gollapudi BB; Boverhof DR
Toxicol Sci; 2012 Apr; 126(2):413-25. PubMed ID: 22302311
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of auricular lymph node cell lymphocyte proliferation and cytokine production as non-radioactive endpoints during murine contact allergy.
Ulker OC; Atak A; Ates I; Karakaya A
J Immunotoxicol; 2011 Jun; 8(2):131-9. PubMed ID: 21275877
[TBL] [Abstract][Full Text] [Related]
17. Characterization and evaluation of a modified local lymph node assay using ATP content as a non-radio isotopic endpoint.
Idehara K; Yamagishi G; Yamashita K; Ito M
J Pharmacol Toxicol Methods; 2008; 58(1):1-10. PubMed ID: 18462956
[TBL] [Abstract][Full Text] [Related]
18. Use of an ex vivo local lymph node assay to assess contact hypersensitivity potential.
Piccotti JR; Kawabata TT
J Immunotoxicol; 2008 Jul; 5(3):271-7. PubMed ID: 18830887
[TBL] [Abstract][Full Text] [Related]
19. Comparison of BALB/c and CBA/J mice for the local lymph node assay using bromodeoxyuridine with flow cytometry (LLNA: BrdU-FCM).
Lee YS; Yi JS; Seo SJ; Kim JH; Jung MS; Seo IK; Ahn I; Ko K; Kim TS; Lim KM; Sohn S
Regul Toxicol Pharmacol; 2017 Feb; 83():13-22. PubMed ID: 27816673
[TBL] [Abstract][Full Text] [Related]
20. Development of LLNA:DAE: a new local lymph node assay that includes the elicitation phase, discriminates borderline-positive chemicals, and is useful for cross-sensitization testing.
Yamashita K; Shinoda S; Hagiwara S; Itagaki H
J Toxicol Sci; 2014 Feb; 39(1):147-61. PubMed ID: 24418719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
